medical innovation

Clinician in blue scrubs holding a patient’s hand in a hospital bed

October 14, 2025

Huntington’s: FuRST 2.0 targets early function; AMT-130’s 3-year percent is inside

Health • Patient-Centered FuRST 2.0 for Huntington’s: early daily changes, made measurable Interactive explainer and quick market context on QURE from your supplied text. FuRST 2.0 is a patient‑reported outcome measure built

Professor Ed Wild and Professor Sarah Tabrizi from UCL's Huntington's Disease Centre standing together in a laboratory wearing white lab coats with UCL insignia.

Health·News·Science

Gene Therapy Slows Huntington’s Disease by 75% in Clinical Trial

A new gene therapy called AMT-130 has successfully slowed the progression of Huntington’s disease by 75% in clinical trials, marking the first time any treatment has effectively slowed this devastating neurological condition. Developed by uniQure, the one-time treatment was tested

September 24, 2025

Stanford’s Hair-Thin NeuroString Packs 1,280 Electronic Channels to Monitor and Stimulate Body Tissues

Artificial Intelligence·Health·Science·Technology

Stanford researchers have developed a remarkable new technology called Spiral-NeuroString (S-NeuroString), a soft electronic fiber about the width of a human hair that can

Harvard AI Tool Ranks Disease Targets 35% Higher, Processes Data 25× Faster Than Competitors

Artificial Intelligence·Health·News

Harvard Medical School researchers have created a new AI tool that could transform how doctors treat Parkinson’s, Alzheimer’s, and even cancer. The system, called

Two vaccine vials with blue caps, one standing upright and one lying on its side, labeled as mRNA vaccine against a light blue background.

Health·News·USA

Russia’s Enteromix Cancer Vaccine Shows 80% Tumor Reduction

Russia has developed a cancer vaccine called Enteromix that’s now ready for clinical use, according to an announcement by Veronika Skvortsova, head of Russia’s Federal Medical and Biological Agency (FMBA). She shared

Tejal Somvanshi

September 8, 2025

Professor Richard Scolyer lying on a Canon Aquilion CT scanner bed in a hospital room, wearing a light blue hospital gown, preparing for a brain scan as part of his glioblastoma treatment.

Australia·Health·News

Richard Scolyer’s Brain Cancer ‘Getting Closer to End Point’ as Government Commits $5.9M for Research Chair

Former Australian of the Year Richard Scolyer says his battle with aggressive brain cancer is “getting closer to an end point,” as the federal government announces a $5.9 million commitment to establish

Tejal Somvanshi

September 3, 2025

Health·Nature·Science

Eight Healthy Babies Born Using Three-Person DNA: UK Mitochondrial Replacement Breakthrough

When Poppy was born, doctors told her mother Kat there was no cure for mitochondrial disease. Now 14, Poppy uses a wheelchair, cannot speak, and relies on tube feeding. But for families

Karmactive Team

July 23, 2025

Health·News

Adaptive DBS Cuts Energy Use by 40% as FDA Approves BrainSense™ for Parkinson’s

A brain pacemaker that can actually hear and respond to your brain’s signals may sound like science fiction, but for people with Parkinson’s disease, this technology is now reality. The FDA approved

Tejal Somvanshi

July 23, 2025

Health

Stanford Breakthrough: Single Molecule Boosts Aging Muscle Strength 15-20% in One Month

A groundbreaking discovery from Stanford University researchers shows that a single dose of a naturally occurring molecule called prostaglandin E2 (PGE2) can significantly restore muscle strength and function in aged mice. This

Tejal Somvanshi

June 26, 2025

Blood tests are a laboratory examination of blood, which is the main diagnostic test for most diseases. (CC0 1.0)

Australia·Health·News

Australian Blood Test Ends Gluten Challenge Nightmare for 80% of Undiagnosed Coeliac Disease Patients

A new blood test developed in Australia promises to transform how coeliac disease is diagnosed, removing the need for patients to eat gluten – the very substance that makes them ill. For

Tejal Somvanshi

June 10, 2025

Stanford Milli-Spinner Hits 90% Success Rate for Stroke Clots

Health

Stanford’s Milli-Spinner Achieves 90% First-Try Success for Toughest Stroke Clots

Stanford University researchers have developed a groundbreaking device called the “milli-spinner thrombectomy” that removes blood clots more effectively than current methods. This innovation, published in Nature on June 4, 2025, could transform

Tejal Somvanshi

June 10, 2025